Podor TJ - Search Results

1

Kinetics of inactivation of alpha-thrombin by plasminogen activator inhibitor-1. Comparison of the effects of native and urea-treated forms of vitronectin.

Naski MC, Lawrence DA, Mosher DF, Podor TJ, Ginsburg D. Naski MC, et al. Among authors: podor tj. J Biol Chem. 1993 Jun 15;268(17):12367-72. J Biol Chem. 1993. PMID: 7685341 Free article.

2

Type 1 plasminogen activator inhibitor binds to fibrin via vitronectin.

Podor TJ, Peterson CB, Lawrence DA, Stefansson S, Shaughnessy SG, Foulon DM, Butcher M, Weitz JI. Podor TJ, et al. J Biol Chem. 2000 Jun 30;275(26):19788-94. doi: 10.1074/jbc.M908079199. J Biol Chem. 2000. PMID: 10764803 Free article.

3

New insights into the size and stoichiometry of the plasminogen activator inhibitor type-1.vitronectin complex.

Podor TJ, Shaughnessy SG, Blackburn MN, Peterson CB. Podor TJ, et al. J Biol Chem. 2000 Aug 18;275(33):25402-10. doi: 10.1074/jbc.M000362200. J Biol Chem. 2000. PMID: 10821827 Free article.

4

Vimentin exposed on activated platelets and platelet microparticles localizes vitronectin and plasminogen activator inhibitor complexes on their surface.

Podor TJ, Singh D, Chindemi P, Foulon DM, McKelvie R, Weitz JI, Austin R, Boudreau G, Davies R. Podor TJ, et al. J Biol Chem. 2002 Mar 1;277(9):7529-39. doi: 10.1074/jbc.M109675200. Epub 2001 Dec 14. J Biol Chem. 2002. PMID: 11744725 Free article.

5

Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells. Induction by transforming growth factor-beta, lipopolysaccharide, and tumor necrosis factor-alpha.

Sawdey M, Podor TJ, Loskutoff DJ. Sawdey M, et al. Among authors: podor tj. J Biol Chem. 1989 Jun 25;264(18):10396-401. J Biol Chem. 1989. PMID: 2499579 Free article.

6

Incorporation of vitronectin into fibrin clots. Evidence for a binding interaction between vitronectin and gamma A/gamma' fibrinogen.

Podor TJ, Campbell S, Chindemi P, Foulon DM, Farrell DH, Walton PD, Weitz JI, Peterson CB. Podor TJ, et al. J Biol Chem. 2002 Mar 1;277(9):7520-8. doi: 10.1074/jbc.M109677200. Epub 2001 Dec 14. J Biol Chem. 2002. PMID: 11744726 Free article.

7

Accumulation of type 1 plasminogen activator inhibitor and vitronectin at sites of cellular necrosis and inflammation.

Podor TJ, Joshua P, Butcher M, Seiffert D, Loskutoff D, Gauldie J. Podor TJ, et al. Ann N Y Acad Sci. 1992 Dec 4;667:173-7. doi: 10.1111/j.1749-6632.1992.tb51609.x. Ann N Y Acad Sci. 1992. PMID: 1285020 No abstract available.

8

Differential mechanisms targeting type 1 plasminogen activator inhibitor and vitronectin into the storage granules of a human megakaryocytic cell line.

Hill SA, Shaughnessy SG, Joshua P, Ribau J, Austin RC, Podor TJ. Hill SA, et al. Among authors: podor tj. Blood. 1996 Jun 15;87(12):5061-73. Blood. 1996. PMID: 8652819 Free article.

9

Evidence that postoperative fibrinolytic shutdown is mediated by plasma factors that stimulate endothelial cell type I plasminogen activator inhibitor biosynthesis.

Kassis J, Hirsh J, Podor TJ. Kassis J, et al. Among authors: podor tj. Blood. 1992 Oct 1;80(7):1758-64. Blood. 1992. PMID: 1391943 Free article.

10

Cytokeratin 18 is expressed on the hepatocyte plasma membrane surface and interacts with thrombin-antithrombin complexes.

Wells MJ, Hatton MW, Hewlett B, Podor TJ, Sheffield WP, Blajchman MA. Wells MJ, et al. Among authors: podor tj. J Biol Chem. 1997 Nov 7;272(45):28574-81. doi: 10.1074/jbc.272.45.28574. J Biol Chem. 1997. PMID: 9353322 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters